Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year

Dermatol Ther (Heidelb). 2022 Jan 7. doi: 10.1007/s13555-021-00657-y. Online ahead of print.

Abstract

Video (MP4 113130 kb).

Trial registration: ClinicalTrials.gov NCT02260986.

Keywords: Atopic dermatitis; Dupilumab; Efficacy; Long-term; Outcome measures.

Publication types

  • Letter

Associated data

  • ClinicalTrials.gov/NCT02260986